MedTrace Logo

Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis

NCT00744952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2018-10-19

No results posted yet for this study

Summary

Assessing disease activity in people with Takayasu's arteritis is difficult, as most people with the disease do not exhibit visible, measurable symptoms. Combination positron emission tomography/computed axial tomography (PET/CT) is a particularly sensitive, accurate scanning method that may improve researchers' ability to evaluate people with the disease. This study will determine the effectiveness of PET/CT in assessing disease activity in people with Takayasu's arteritis.

Conditions

  • Takayasu Arteritis

Sponsors & Collaborators

  • Office of Rare Diseases (ORD)

    collaborator NIH

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Rare Diseases Clinical Research Network

    collaborator NETWORK

  • Peter Merkel

    lead OTHER

Principal Investigators

  • Peter A. Merkel, MD, MPH · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00744952 on ClinicalTrials.gov